NIT
ATRA icon

NumerixS Investment Technologies’s Atara Biotherapeutics ATRA Stock Holding History

NumerixS Investment Technologies’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-127
Closed -$27K – 1067
2020
Q1 		$27K Buy
+127
New +$40.3K 0.01% 743
2019
Q3 		– Sell
-542
Closed -$272K – 1007
2019
Q2 		$272K Buy
+542
New +$383K 0.08% 315
2018
Q4 		– Sell
-132
Closed -$135K – 1078
2018
Q3 		$135K Buy
+132
New +$129K 0.03% 717

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

NumerixS Investment Technologies's ATRA Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Atara Biotherapeutics (ATRA) in Q2 2020, closing a stake of 127 shares — an estimated $27K sold.

NumerixS Investment Technologies first reported a position in ATRA in Q3 2018 and held it in 3 quarters. The position peaked at $272K in Q2 2019. 122 funds tracked by Wall St. Rank hold ATRA as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Atara Biotherapeutics position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 127 Atara Biotherapeutics shares in Q2 2020, an estimated $27K.
  • NumerixS Investment Technologies first reported a position in Atara Biotherapeutics in Q3 2018 and held it in 3 quarters.
  • NumerixS Investment Technologies's Atara Biotherapeutics position peaked at $272K in Q2 2019.
  • 122 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.